Utility of PHQ-2, PHQ-8 and PHQ-9 for detecting major depression in primary health care: a validation study in Spain.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
09 2023
Historique:
medline: 6 10 2023
pubmed: 20 10 2022
entrez: 19 10 2022
Statut: ppublish

Résumé

Primary health care (PHC) professionals may play a crucial role in improving early diagnosis of depressive disorders. However, only 50% of cases are detected in PHC. The most widely used screening instrument for major depression is the Patient Health Questionnaire (PHQ), including the two-, eight- and nine-item versions. Surprisingly, there is neither enough evidence about the validity of PHQ in PHC patients in Spain nor indications about how to interpret the total scores. This study aimed to gather validity evidence to support the use of the three PHQ versions to screen for major depression in PHC in Spain. Additionally, the present study provided information for helping professionals to choose the best PHQ version according to the context. The sample was composed of 2579 participants from 22 Spanish PHC centers participating in the EIRA-3 study. The reliability and validity of the three PHQ versions for Spanish PHC patients were assessed based on responses to the questionnaire. The PHQ-8 and PHQ-9 showed high internal consistency. The results obtained confirm the theoretically expected relationship between PHQ results and anxiety, social support and health-related QoL. A single-factor solution was confirmed. Regarding to the level of agreement with the CIDI interview (used as the criterion), our results indicate that the PHQ has a good discrimination power. The optimal cut-off values were: ⩾2 for PHQ-2, ⩾7 for PHQ-8 and ⩾8 for PHQ-9. PHQ is a good and valuable tool for detecting major depression in PHC patients in Spain.

Sections du résumé

BACKGROUND
Primary health care (PHC) professionals may play a crucial role in improving early diagnosis of depressive disorders. However, only 50% of cases are detected in PHC. The most widely used screening instrument for major depression is the Patient Health Questionnaire (PHQ), including the two-, eight- and nine-item versions. Surprisingly, there is neither enough evidence about the validity of PHQ in PHC patients in Spain nor indications about how to interpret the total scores. This study aimed to gather validity evidence to support the use of the three PHQ versions to screen for major depression in PHC in Spain. Additionally, the present study provided information for helping professionals to choose the best PHQ version according to the context.
METHODS
The sample was composed of 2579 participants from 22 Spanish PHC centers participating in the EIRA-3 study. The reliability and validity of the three PHQ versions for Spanish PHC patients were assessed based on responses to the questionnaire.
RESULTS
The PHQ-8 and PHQ-9 showed high internal consistency. The results obtained confirm the theoretically expected relationship between PHQ results and anxiety, social support and health-related QoL. A single-factor solution was confirmed. Regarding to the level of agreement with the CIDI interview (used as the criterion), our results indicate that the PHQ has a good discrimination power. The optimal cut-off values were: ⩾2 for PHQ-2, ⩾7 for PHQ-8 and ⩾8 for PHQ-9.
CONCLUSIONS
PHQ is a good and valuable tool for detecting major depression in PHC patients in Spain.

Identifiants

pubmed: 36258639
doi: 10.1017/S0033291722002835
pii: S0033291722002835
pmc: PMC10482708
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5625-5635

Auteurs

Irene Gómez-Gómez (I)

Department of Psychology, Universidad Loyola Andalucía, Dos Hermanas, Seville, Spain.
Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.

Isabel Benítez (I)

Department of Methodology of Behavioral Sciences, Universidad de Granada, Granada, Spain.

Juan Bellón (J)

Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
Biomedical Research Institute of Málaga (IBIMA), Málaga, Spain.
El Palo Health Centre, Andalusian Health Service (SAS), Málaga, Spain.
Department of Public Health and Psychiatry, University of Málaga (UMA), Málaga, Spain.

Patricia Moreno-Peral (P)

Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
Biomedical Research Institute of Málaga (IBIMA), Málaga, Spain.

Bárbara Oliván-Blázquez (B)

Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
Department of Psychology and Sociology, Universidad de Zaragoza, Zaragoza, Spain.
Institute for Health Research Aragón (IISA), Zaragoza, Spain.

Ana Clavería (A)

Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
Primary Care Research Unit, Área de Vigo, SERGAS, Vigo, Spain.
I-Saúde Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.

Edurne Zabaleta-Del-Olmo (E)

Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Atenció Primària Barcelona Ciutat, Gerència Territorial de Barcelona, Institut Català de la Salut, Barcelona, Spain.
Nursing department, Faculty of Nursing, Universitat de Girona, Girona, Spain.

Joan Llobera (J)

Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Maria J Serrano-Ripoll (MJ)

Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Olaya Tamayo-Morales (O)

Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.

Emma Motrico (E)

Department of Psychology, Universidad Loyola Andalucía, Dos Hermanas, Seville, Spain.
Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH